Snaebjarnardóttir Kolfinna, Erlendsdóttir Helga, Reynisson Ingi Karl, Kristinsson Karl, Halldórsdóttir Sandra, Hardardóttir Hjördís, Gudnason Thórólfur, Gottfredsson Magnús, Haraldsson Ásgeir
From the University of Iceland Faculty of Medicine.
Scand J Infect Dis. 2013 Nov;45(11):819-24. doi: 10.3109/00365548.2013.817680. Epub 2013 Aug 23.
Bacterial meningitis is a serious and potentially rapid life-threatening disease. Therefore, to ensure appropriate treatment, early recognition of signs and symptoms is imperative, along with knowledge of the epidemiology and microbiology of the disease.
A long-term, nationwide epidemiological study of bacterial causes of meningitis in children (≤ 18 y) in Iceland during the period 1975-2010 was carried out. A detailed chart review was performed of all cases diagnosed in 1995-2010.
A total of 477 children were diagnosed with bacterial meningitis during the period 1975-2010. Of these, 67% were aged under 5 y. The most common pathogens were Neisseria meningitidis (n = 265), Haemophilus influenzae (n = 132), Streptococcus pneumoniae (n = 47), and Streptococcus agalactiae (n = 19); their incidences varied according to age. The age-specific incidence (cases/100,000/y) dropped from 26 in 1975 to 1 in 2010 (p < 0.001). The most common symptoms during the period 1995-2010 were fever (92%), vomiting (67%), nuchal rigidity (60%), and rashes/petechiae (51%). H. influenzae type b disappeared following implementation of Hib vaccination in 1989, and, likewise, the incidence of meningococcal meningitis fell significantly after vaccination against meningococcus serogroup C was initiated in 2002 (p < 0.001). The overall 30-day case fatality rate of bacterial meningitis was 4.4% and remained unchanged during the study period.
The incidence of childhood bacterial meningitis has been reduced significantly by successful vaccinations against H. influenzae type b and N. meningitidis serogroup C. Nevertheless, the case fatality rate has remained unchanged and thus the disease is still a serious threat to childhood health. Further prevention by novel vaccines and improved management of childhood meningitis is an exciting challenge.
细菌性脑膜炎是一种严重且可能迅速危及生命的疾病。因此,为确保恰当治疗,必须尽早识别症状体征,并了解该疾病的流行病学和微生物学知识。
对1975年至2010年期间冰岛18岁及以下儿童细菌性脑膜炎病因进行了一项长期的全国性流行病学研究。对1995年至2010年期间诊断的所有病例进行了详细的病历审查。
1975年至2010年期间,共有477名儿童被诊断为细菌性脑膜炎。其中,67%年龄在5岁以下。最常见的病原体是脑膜炎奈瑟菌(n = 265)、流感嗜血杆菌(n = 132)、肺炎链球菌(n = 47)和无乳链球菌(n = 19);它们的发病率随年龄而异。年龄特异性发病率(每100,000人/年的病例数)从1975年的26降至2010年的1(p < 0.001)。1995年至2010年期间最常见的症状是发热(92%)、呕吐(67%)、颈项强直(60%)和皮疹/瘀点(51%)。1989年实施b型流感嗜血杆菌疫苗接种后,b型流感嗜血杆菌消失,同样,2002年开始接种C群脑膜炎球菌疫苗后,脑膜炎球菌性脑膜炎的发病率显著下降(p < 0.001)。细菌性脑膜炎的总体30天病死率为4.4%,在研究期间保持不变。
针对b型流感嗜血杆菌和C群脑膜炎奈瑟菌的成功疫苗接种显著降低了儿童细菌性脑膜炎的发病率。然而,病死率保持不变,因此该疾病仍然是儿童健康的严重威胁。通过新型疫苗进一步预防和改善儿童脑膜炎的管理是一项令人振奋的挑战。